#Virtual Pharma
Explore articles tagged with Virtual Pharma
HRV Pharma Honoured at ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support
HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
Union Budget 2026–27: Strengthening India’s Biopharma Ecosystem and Healthcare Access
HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.
How Virtual Manufacturing Is Solving Structural Causes of Global Drug Shortages
Virtual pharmaceutical manufacturing models are helping solve structural drug shortages by connecting global GMP capacity, improving supply flexibility, and strengthening regulatory execution.
HRV Pharma Partners with Haleos Labs to Accelerate Orphan and Niche API Development
HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.
How HRV Pharma’s Virtual Model Helps Solve America’s Drug Shortage Crisis
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.